{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:30:00Z","timestamp":1785558600156,"version":"3.56.0"},"reference-count":32,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Cardiol"],"abstract":"<jats:p>Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for patients with severe aortic valve stenosis or regurgitation, especially those at intermediate-to-high surgical risk. As TAVR indications expand, the patient population is progressively younger, increasing the likelihood of bioprosthetic valve failure (BVF) over time. This shift highlights the need for effective long-term management strategies. This review focuses on the evolving role of redo-TAVR, specifically the TAV-in-TAV approach, for managing BVF. Key challenges include coronary obstruction, valve migration and device selection. Preprocedural planning, particularly through advanced imaging techniques, such as CT, is critical if complications are to be minimised. This review discusses important technical considerations for TAV-in-TAV procedures, including valve sizing, implantation depth and the impact of valve design on coronary access. A multidisciplinary heart team is essential for assessing patient anatomy and appropriate device selection. Although outcomes appear promising, further research is required to refine procedural techniques and optimise long-term results for patients undergoing redo-TAVR.<\/jats:p>","DOI":"10.15420\/ecr.2025.05","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:04:36Z","timestamp":1783537476000},"source":"Crossref","is-referenced-by-count":1,"title":["Redo Transcatheter Aortic Valve Replacement: Device Selection and Risks"],"prefix":"10.15420","author":[{"given":"Tommaso","family":"Fabris","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00240q980","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Padua"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4830-0354","authenticated-orcid":false,"given":"Francesco","family":"Putort\u00ec","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00240q980","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Padua"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-2269","authenticated-orcid":false,"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00240q980","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Padua"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Cribier A, Eltchaninoff H. Transcatheter aortic valve implantation: two decades of a revolutionary and ongoing odyssey. Circulation 2024;150:821\u20132. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.068237; PMID:\u00a039250536.","DOI":"10.1161\/CIRCULATIONAHA.124.068237"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597\u2013607. https:\/\/doi.org\/10.1056\/NEJMoa1008232.","DOI":"10.1056\/NEJMoa1008232"},{"key":"ref2","unstructured":"Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1514616; PMID:\u00a027040324."},{"key":"ref3","unstructured":"Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695\u2013705. https:\/\/doi.org\/10.1056\/NEJMoa1814052; PMID:\u00a030883058."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Tarantini G, Nai Fovino L, Gersh BJ. Transcatheter aortic valve implantation in lower-risk patients: what is the perspective? Eur Heart J 2018;39:658\u201366. https:\/\/doi.org\/10.1093\/eurheartj\/ehx489; PMID:\u00a029020347.","DOI":"10.1093\/eurheartj\/ehx489"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Basman C, Pirelli L, Singh VP, et al. Lifetime management for aortic stenosis: planning for future therapies. J Cardiol 2022;80:185\u20139. https:\/\/doi.org\/10.1016\/j.jjcc.2021.12.010; PMID:\u00a035016808.","DOI":"10.1016\/j.jjcc.2021.12.010"},{"key":"ref6","unstructured":"VARC-3 Writing Committee. Valve Academic Research Consortium 3: Updated endpoint definitions for aortic\u00a0valve clinical research. J Am Coll Cardiol 2021;77:2717\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.038; PMID:\u00a033888385."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Thyregod HGH, J\u00f8rgensen TH, Ihlemann N, et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J 2024;45:1116\u201324. https:\/\/doi.org\/10.1093\/eurheartj\/ehae043; PMID:\u00a038321820.","DOI":"10.1093\/eurheartj\/ehae043"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Barbanti M, Costa G, Zappulla P, et al. Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement. J Am Heart Assoc 2018;7:e008440. https:\/\/doi.org\/10.1161\/JAHA.117.008440; PMID:\u00a030371244.","DOI":"10.1161\/JAHA.117.008440"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Fukuhara S, Tanaka D, Brescia AA, et al. Aortic valve reintervention in patients with failing transcatheter aortic bioprostheses: a statewide experience. J Thorac Cardiovasc Surg 2023;165:2011\u20132020.e5. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.08.057; PMID:\u00a034538638.","DOI":"10.1016\/j.jtcvs.2021.08.057"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Makkar RR, Kapadia S, Chakravarty T, et al. Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study. Lancet 2023;402:1529\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(23)01636-7; PMID:\u00a037660719.","DOI":"10.1016\/S0140-6736(23)01636-7"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Tarantini G, Sathananthan J, Fabris T, et al. Transcatheter aortic valve replacement in failed transcatheter bioprosthetic valves. JACC Cardiovasc Interv 2022;15:1777\u201393. https:\/\/doi.org\/10.1016\/j.jcin.2022.07.035; PMID:\u00a036137681.","DOI":"10.1016\/j.jcin.2022.07.035"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bapat VN. A guide to transcatheter aortic valve design and systematic planning for a redo-TAV (TAV-in-TAV) procedure. JACC Cardiovasc Interv 2024;17:1631\u201351. https:\/\/doi.org\/10.1016\/j.jcin.2024.04.047; PMID:\u00a039048251.","DOI":"10.1016\/j.jcin.2024.04.047"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Testa L, Agnifili M, Van Mieghem NM, et al. Transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT international project. Circ Cardiovasc Interv 2021;14:e010440. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.010440; PMID:\u00a034092097.","DOI":"10.1161\/CIRCINTERVENTIONS.120.010440"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Attizzani GF, Dallan LAP, Forrest JK, et al. Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: insights from the Transcatheter Valve Therapy Registry. Catheter Cardiovasc Interv 2022;99:869\u201376. https:\/\/doi.org\/10.1002\/ccd.29941; PMID:\u00a034533891.","DOI":"10.1002\/ccd.29941"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Barbanti M, Webb JG, Tamburino C, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv 2016;9:e003930. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.003930; PMID:\u00a027578840.","DOI":"10.1161\/CIRCINTERVENTIONS.116.003930"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Nagasaka T, Patel V, Koren O, et al. TAVR-in-TAVR with a balloon-expandable valve for paravalvular leak. Front Cardiovasc Med 2024;11:1374078. https:\/\/doi.org\/10.3389\/fcvm.2024.1374078; PMID:\u00a038566964.","DOI":"10.3389\/fcvm.2024.1374078"},{"key":"ref17","unstructured":"Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv 2019;12:1240\u201352. https:\/\/doi.org\/10.1016\/j.jcin.2019.03.035; PMID:\u00a031202947."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Buzzatti N, Montorfano M, Romano V, et al. A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation. EuroIntervention 2020;16:e1005\u201313. https:\/\/doi.org\/10.4244\/EIJ-D-20-00475; PMID:\u00a032928715.","DOI":"10.4244\/EIJ-D-20-00475"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"De Backer O, Landes U, Fuchs A, et al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography. JACC Cardiovasc Interv 2020;13:2528\u201338. https:\/\/doi.org\/10.1016\/j.jcin.2020.06.016; PMID:\u00a033153567.","DOI":"10.1016\/j.jcin.2020.06.016"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Fukui M, Bapat VN, Garcia S, et al. Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes. Circulation 2022;146:480\u201393. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.058339; PMID:\u00a035862182.","DOI":"10.1161\/CIRCULATIONAHA.121.058339"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart 2006;92:1022\u20139. https:\/\/doi.org\/10.1136\/hrt.2005.067363; PMID:\u00a016251232.","DOI":"10.1136\/hrt.2005.067363"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Seiffert M, Conradi L, Baldus S, et al. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses. J Thorac Cardiovasc Surg 2012;143:617\u201324. https:\/\/doi.org\/10.1016\/j.jtcvs.2011.11.004; PMID:\u00a022169448.","DOI":"10.1016\/j.jtcvs.2011.11.004"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Testa L, Casenghi M, Criscione E, et al. Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT-PPM international project. Front Cardiovasc Med 2022;9:931207. https:\/\/doi.org\/10.3389\/fcvm.2022.931207; PMID:\u00a035966561.","DOI":"10.3389\/fcvm.2022.931207"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Dayan V, Vignolo G, Soca G, et al. Predictors and outcomes of prosthesis-patient mismatch after\u00a0aortic\u00a0valve replacement. JACC Cardiovasc Imaging 2016;9:924\u201333. https:\/\/doi.org\/10.1016\/j.jcmg.2015.10.026; PMID:\u00a027236530.","DOI":"10.1016\/j.jcmg.2015.10.026"},{"key":"ref25","unstructured":"Guthoff H, Abdel-Wahab M, Kim WK, et al. Impact of measured and predicted prosthesis-patient mismatch after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2024;17:2626\u201335. https:\/\/doi.org\/10.1016\/j.jcin.2024.08.041; PMID:\u00a039603776."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Akodad M, Meier D, Sellers S, et al. A bench study of balloon-expandable valves for the treatment of self-expanding valve failure. EuroIntervention 2023;19:93\u2013102. https:\/\/doi.org\/10.4244\/EIJ-D-22-00769; PMID:\u00a036621917.","DOI":"10.4244\/EIJ-D-22-00769"},{"key":"ref27","unstructured":"Meier D, Fournier S, Sathananthan J. Redo TAVR: Technical considerations. Cardiac Interventions Today 2023;17:63\u201366."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Zaid S, Bapat VN, Sathananthan J, et al. Challenges and future directions in redo aortic valve reintervention after transcatheter aortic valve replacement failure. Circ Cardiovasc Interv 2023;16:e012966. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.123.012966; PMID:\u00a037988437.","DOI":"10.1161\/CIRCINTERVENTIONS.123.012966"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Tarantini G, Tang GHL, Pilgrim T, et al. Clinical characteristics and outcomes of\u00a0patients undergoing 3 aortic valve interventions: the THIRD multicenter registry. JACC Cardiovasc Interv 2025;18:103\u201315. https:\/\/doi.org\/10.1016\/j.jcin.2024.10.037; PMID:\u00a039814484.","DOI":"10.1016\/j.jcin.2024.10.037"},{"key":"ref30","unstructured":"Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol 2020;75:1882\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.051; PMID: 32327098."},{"key":"ref31","unstructured":"Makkar RR, Yoon SH, Chakravarty T, et al. Real-world outcomes of bicuspid aortic stenosis treated with the SAPIEN 3 platform: an analysis of 591 patients from the STS\/ACC TVT Registry. Presented at: Transcatheter Valve Therapy (TVT) Scientific Sessions. 20\u201322 July 2021, Miami, FL, US."}],"container-title":["European Cardiology Review"],"original-title":[],"link":[{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2025.05","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:04:42Z","timestamp":1783537482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2025.05"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":32,"URL":"https:\/\/doi.org\/10.15420\/ecr.2025.05","relation":{},"ISSN":["1758-3756","1758-3764"],"issn-type":[{"value":"1758-3756","type":"print"},{"value":"1758-3764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"e41"}}